The study design included sequential rounds of a three-day vehicle-treated baseline phase, a three-day treatment phase, and a two-to-three-day washout phase
Randomized controlled trials before the issue of CVOTs by the FDA in 2008 mainly focused on the efficacy of the blood glucose-lowering effects and a broad spectrum of adverse effects, with limited numbers of cardiovascular adverse events and relatively short follow-up duration
Some of them took one of the older GLP-1 drugs, such as liraglutide (Saxenda, Victoza), dulaglutide (Trulicity), exenatide (Byetta), or lixisenatide (Adlyxin)
How long does it take for GLP-1s to work
1,811 The major challenges in the research and drug development for NASH mainly focus on two outcomes
Eligibility for GLP-1 Injections: Adults with a BMI of 30 or higher (classified as obese)